Skip to content

Search

Showing results for " https://www.galaxus.ch/en/sector/showdiscussion/freesnapchathack-visit-kunghaccom-t1tzlqbw-226931"

Measuring use and cost of health sector and related care in a population of girls and young women with Rett syndrome

This study measured use and cost of health sector and related services in Rett syndrome and effects of socio-demographic, clinical severity and genetic...

Omnipod DASH is in Australia

You may have heard that Insulet has released the Omnipod DASH system in Australia. The DASH consists of a tubeless “pod” pump which pairs with a touchscreen Bluetooth® enabled controller.

Ready for a sea-faring adventure?

Diabetes WA and Leeuwin Ocean Adventure Foundation are on the hunt for two young people aged 16-18 years with type 1 diabetes to participate in the Leeuwin Ocean Adventure Youth Explorer Voyage in the upcoming October school holidays.

Guardian 4 sensor

The Guardian 4 sensor have recently been approved by the Therapeutic Goods Administration for use in Australia.

Visit from On Track Watch Community Researchers helps build a pathway of looking at two different cultures

For Aboriginal Community Researchers Minitja Marawili and Yunutju Gondarra, the work of the END RHD CRE is deeply personal.

Cybersecurity awareness

Technology is an important part of diabetes management but its important to stay cybersecurity aware.

Go play for the International Day of Play

Did you know our research shows that less than 20 per cent of young Australian children get enough energetic play each day? Many children are spending more time sitting still or on screens, and not enough time moving, exploring and playing, which is fundamental to their healthy development.

SNAP-Chat: the Staphylococcus aureus Network Adaptive Platform Trial (SNAP) - Chat

Dr Anita Asha Campbell Bowen MBBS, DCH, PG DipPID, FRACP, PhD BA MBBS DCH FRACP PhD GAICD FAHMS OAM Infectious Diseases Physician; Raine Clinician

Same-visit hepatitis C testing and treatment to accelerate cure among people who inject drugs (the QuickStart Study): A cluster randomised cross-over trial protocol

Despite universal access to government-funded direct-acting antivirals in 2016, the rate of hepatitis C treatment uptake in Australia has declined substantially. Most hepatitis C is related to injecting drug use; reducing the hepatitis C burden among people who inject drugs is, therefore, paramount to reach hepatitis C elimination targets. 

ENDIA milestone

Australia’s biggest study into the causes of type 1 diabetes recently recruited its 1500th and final participant right here in WA.